Table of Contents
Conference Papers in Science
Volume 2015 (2015), Article ID 593086, 9 pages
http://dx.doi.org/10.1155/2015/593086
Conference Paper

Local Angiotensin Pathways in Human Carotid Atheroma: Towards a Systems Biology Approach

1EA4173-Functional Genomics in Hypertension, Université de Lyon, Hôpital Nord-Ouest, Villefranche, Lyon, France
2Service de Pharmacologie, INSERM U1088, Centre de Biologie Humaine, CHU Amiens, avenue Laennec, Salouel, 80000 Amiens, France

Received 19 June 2014; Revised 21 December 2014; Accepted 30 December 2014

Academic Editor: Antonio Lepedda

This Conference Paper is based on a presentation given by Giampiero Bricca at “LIAC Meeting on Vascular Research 2013” held from 18 September 2013 to 21 September 2013 in Alghero, Italy.

Copyright © 2015 Giampiero Bricca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. von Bertalanffy, General System Theory: Foundations, Development, Applications, George Braziller, New York, NY, USA, 1968.
  2. A. C. Guyton, T. G. Coleman, and H. J. Granger, “Circulation: overall regulation,” Annual Review of Physiology, vol. 34, pp. 13–44, 1972. View at Publisher · View at Google Scholar
  3. R. Moss, T. Grosse, I. Marchant, N. Lassau, F. Gueyffier, and S. R. Thomas, “Virtual patients and sensitivity analysis of the Guyton model of blood pressure regulation: towards individualized models of whole-body physiology,” PLoS Computational Biology, vol. 8, no. 6, Article ID e1002571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Montani and B. N. van Vliet, “Understanding the contribution of Guyton's large circulatory model to long-term control of arterial pressure,” Experimental Physiology, vol. 94, no. 4, pp. 382–388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Claassen, S. Willmann, T. Eissing, T. Preusser, and M. Block, “A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine renin-angiotensin-aldosterone system,” Frontiers in Physiology, vol. 4, article 4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. D. T. Lackland, “Hypertension: joint national committee on detection, evaluation, and treatment of high blood pressure guidelines,” Current Opinion in Neurology, vol. 26, no. 1, pp. 8–12, 2013. View at Publisher · View at Google Scholar
  7. R. S. McKelvie, G. W. Moe, J. A. Ezekowitz et al., “The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure,” Canadian Journal of Cardiology, vol. 29, no. 2, pp. 168–181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Becari, E. B. Oliveira, and M. C. O. Salgado, “Alternative pathways for angiotensin II generation in the cardiovascular system,” Brazilian Journal of Medical and Biological Research, vol. 44, no. 9, pp. 914–919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Herichova and K. Szantoova, “Renin-angiotensin system: upgrade of recent knowledge and perspectives,” Endocrine Regulations, vol. 47, no. 1, pp. 39–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. U. Hilgenfeldt, “Half-life of rat angiotensinogen: influence of nephrectomy and lipopolysaccharide stimulation,” Molecular and Cellular Endocrinology, vol. 56, no. 1-2, pp. 91–98, 1988. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Bohlender, J. Ménard, D. Ganten, and F. C. Luft, “Angiotensinogen concentrations and renin clearance: implications for blood pressure regulation,” Hypertension, vol. 35, no. 3, pp. 780–786, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. D. B. Gordon, “The role of renin substrate in hypertension,” Hypertension, vol. 5, no. 3, pp. 353–362, 1983. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Jeunemaitre, “Genetics of the human renin angiotensin system,” Journal of Molecular Medicine, vol. 86, no. 6, pp. 637–641, 2008. View at Publisher · View at Google Scholar
  14. R. A. Gonzalez-Villalobos, X. Z. Shen, E. A. Bernstein et al., “Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme,” Journal of Molecular Medicine, vol. 91, no. 10, pp. 1143–1154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Swales and H. Thurston, “Generation of angiotensin II at peripheral vascular level: studies using angiotensin II antisera,” Clinical Science, vol. 45, no. 5, pp. 691–700, 1973. View at Google Scholar · View at Scopus
  16. H. Thurston and J. D. Swales, “Action of angiotensin antagonists and antiserum upon the pressor response to renin: further evidence for the local generation of angiotensin II,” Clinical Science and Molecular Medicine, vol. 46, no. 2, pp. 273–276, 1974. View at Google Scholar · View at Scopus
  17. M. Paul, A. P. Mehr, and R. Kreutz, “Physiology of local renin-angiotensin systems,” Physiological Reviews, vol. 86, no. 3, pp. 747–803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Bader and D. Ganten, “Update on tissue renin-angiotensin systems,” Journal of Molecular Medicine, vol. 86, no. 6, pp. 615–621, 2008. View at Publisher · View at Google Scholar
  19. K. Kramkowski, A. Mogielnicki, and W. Buczko, “The physiological significance of the alternative pathways of angiotensin II production,” Journal of Physiology and Pharmacology, vol. 57, no. 4, pp. 529–539, 2006. View at Google Scholar · View at Scopus
  20. M. C. Prieto, R. A. González-Villalobos, F. T. Botros et al., “Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1–7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats,” The American Journal of Physiology—Renal Physiology, vol. 300, no. 3, pp. F749–F755, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Messadi-Laribi, V. Griol-Charhbili, E. Gaies et al., “Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 4, pp. 489–493, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. P. C. Wilson, M.-H. Lee, K. M. Appleton et al., “The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers,” The Journal of Biological Chemistry, vol. 288, no. 26, pp. 18872–18884, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ohishi, K. Yamamoto, and H. Rakugi, “Angiotensin (1–7) and other angiotensin peptides,” Current Pharmaceutical Design, vol. 19, no. 17, pp. 3060–3064, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. G. A. Molnar, C. Lindschau, G. Dubrovska et al., “Glucocorticoid-related signaling effects in vascular smooth muscle cells,” Hypertension, vol. 51, no. 5, pp. 1372–1378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. R. Seckl and B. R. Walker, “Minireview: 11β-hydroxysteroid dehydrogenase type 1—a tissue-specific amplifier of glucocorticoid action,” Endocrinology, vol. 142, no. 4, pp. 1371–1376, 2001. View at Google Scholar · View at Scopus
  26. H. Masuzaki, H. Yamamoto, C. J. Kenyon et al., “Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice,” The Journal of Clinical Investigation, vol. 112, no. 1, pp. 83–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Tauchmanovà, R. Rossi, B. Biondi et al., “Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 4872–4878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. G. P. Vinson, “Angiotensin II, corticosteroids, type II diabetes and the metabolic syndrome,” Medical Hypotheses, vol. 68, no. 6, pp. 1200–1207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Desjardins-Giasson, J. Gutkowska, R. Garcia, and J. Genest, “Renin substrate in rat mesenteric artery,” Canadian Journal of Physiology and Pharmacology, vol. 59, no. 6, pp. 528–532, 1981. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Naftilan, W. M. Zuo, J. Inglefinger, T. J. Ryan Jr., R. E. Pratt, and V. J. Dzau, “Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall,” The Journal of Clinical Investigation, vol. 87, no. 4, pp. 1300–1311, 1991. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Legedz, J. Randon, C. Sessa et al., “Cathepsin G is associated with atheroma formation in human carotid artery,” Journal of Hypertension, vol. 22, no. 1, pp. 157–166, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Hodroj, L. Legedz, N. Foudi et al., “Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 3, pp. 525–531, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Legedz, J. Randon, C. Sessa et al., “Induction of tissue kallikrein in human carotid atheroma does not lead to kallikrein-kinins pathway activation,” Journal of Hypertension, vol. 23, no. 2, pp. 359–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. D. N. Müller, J. Bohlender, K. F. Hilgers et al., “Vascular angiotensin-converting enzyme expression regulates local angiotensin II,” Hypertension, vol. 29, no. 1, pp. 98–104, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Sahara, M. Ikutomi, T. Morita et al., “Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation,” Cardiovascular Research, vol. 101, no. 2, pp. 236–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Dong, C. Zhang, J. B. Feng et al., “Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1270–1276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K.-R. Purushothaman, P. Krishnan, M. Purushothaman et al., “Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1-7 is increased in diabetic atheroma: implications for inflammation and neovascularization,” Cardiovascular Pathology, vol. 22, no. 1, pp. 42–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-P. Fortin, L. Gera, J. Bouthillier, J. M. Stewart, A. Adam, and F. Marceau, “Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta,” Journal of Pharmacology and Experimental Therapeutics, vol. 314, no. 3, pp. 1169–1176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Ayari, L. Legedz, P. Lantelme et al., “Auto-amplification of cortisol actions in human carotid atheroma is linked to arterial remodeling and stroke,” Fundamental and Clinical Pharmacology, vol. 28, no. 1, pp. 53–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Ayari, L. Legedz, C. Cerutti et al., “Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma,” Journal of Molecular Medicine, vol. 92, no. 11, pp. 1201–1208, 2014. View at Publisher · View at Google Scholar